Peter Attia, MD
16 peptide videos from Peter Attia, MD — transcribed, attributed, labeled.
Our label: Physician educator · Lane: Educators · Videos in our library: 16
Every page below is built from that video’s own transcript, banked in our research library. Claims are the speaker’s — attributed, not endorsed. This site publishes no dosing, protocol, or sourcing information.
▶ Watch
Peter Attia MD · Educators
184 - [AMA #29 Sneak Peek] GLP-1 Agonists: The Future of Treating Obesity?
Physician educator
▶ Watch
Peter Attia MD · Educators
314 ‒ Rethinking nutrition science: obesity treatment, GLP-1 agonists, protein, & better research
Physician educator
▶ Watch
Peter Attia MD · Educators
403 ‒ Peptides: separating scientific promise from marketing hype
Physician educator
▶ Watch
Peter Attia MD · Educators
Can GLP-1 agonists like Ozempic, Wegovy, and Mounjaro be used to treat addiction? | Anna Lembke
Physician educator
▶ Watch
Peter Attia MD · Educators
Cause for caution with weight loss drugs like Ozempic | Peter Attia, M.D.
Physician educator
▶ Watch
Peter Attia MD · Educators
Do GLP-1 receptor agonists like Ozempic and Wegovy help slow aging or increase lifespan?
Physician educator
▶ Watch
Peter Attia MD · Educators
GLP-1 agonists and the willpower myth
Physician educator
▶ Watch
Peter Attia MD · Educators
GLP-1 agonists in bodybuilding and weight management: moral and philosophical implications
Physician educator
▶ Watch
Peter Attia MD · Educators
GLP-1s: Safe Dosing, Nutrition & Impact on Longevity | Rhonda Patrick, Ph.D.
Physician educator
▶ Watch
Peter Attia MD · Educators
How do GLP-1 agonists (Ozempic, Wegovy, Mounjaro) effect heart rate and heart rate variablity?
Physician educator
▶ Watch
Peter Attia MD · Educators
New insights on GLP-1 agonists—Ozempic, Wegovy, Mounjaro, and more (AMA 64 sneak peek)
Physician educator
▶ Watch
Peter Attia MD · Educators
Ozempic & other GLP-1 receptor agnonists: the societal impact & controversy of their growing usage
Physician educator
▶ Watch
Peter Attia MD · Educators
Pros & cons of GLP-1 weight loss drugs | Dr. Ralph DeFronzo
Physician educator
▶ Watch
Peter Attia MD · Educators
Pros and cons of GLP-1 weight loss drugs and metformin as a geroprotective agent [AMA 45 sneak peek]
Physician educator
▶ Watch
Peter Attia MD · Educators
Should children be on GLP-1 weight loss drugs? | Dr. Ralph DeFronzo
Physician educator
▶ Watch
Peter Attia MD · Educators
Should GLP-1 agonists like Ozempic and Wegovy be banned for professional athletes?
Physician educator